These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10687418)

  • 1. [Current features of antihypertensive drug treatment].
    Luño J; García de Vinuesa S
    Rev Clin Esp; 1999 Dec; 199(12):834-9. PubMed ID: 10687418
    [No Abstract]   [Full Text] [Related]  

  • 2. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Esnault VL
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846229
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Krut LH
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846227
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Pickering TG
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12840099
    [No Abstract]   [Full Text] [Related]  

  • 6. [Classification and risk stratification in hypertension Recommendations of the European Society for Hypertension (ESH)].
    Zidek W
    MMW Fortschr Med; 2003 Nov; 145(45):41-2. PubMed ID: 14699807
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antihypertensive treatment in the type 2 diabetic].
    Fournier A
    Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
    [No Abstract]   [Full Text] [Related]  

  • 8. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of treatment of hypertension on cardiovascular outcome in type 2 diabetes.
    Migdalis IN
    Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):105-14. PubMed ID: 17974100
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are elderly people with the HOPE criteria prescribed angiotensin-converting enzyme inhibitors?
    Sumukadas D; Witham MD; Struthers AD; McMurdo ME
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):26. PubMed ID: 15136970
    [No Abstract]   [Full Text] [Related]  

  • 13. 2003 Canadian hypertension recommendations. It's not all old hat.
    Petrella RJ
    Can Fam Physician; 2004 Apr; 50():589-90. PubMed ID: 15116805
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood pressure-lowering drugs: essential therapy for some patients with normal blood pressure.
    Fuchs FD
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):771-5. PubMed ID: 15350178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The ALLHAT study: contributions, limitations and prospectives].
    Mancia G
    Ital Heart J Suppl; 2003 Feb; 4(2):77-84. PubMed ID: 12762256
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment.
    Nielsen FS
    Dan Med Bull; 2000 Sep; 47(4):249-70. PubMed ID: 11064829
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive medications and risk of diabetes mellitus.
    Barzilay JI; Cutler JA; Davis BR
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):256-60. PubMed ID: 17420670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment approach for high blood pressure patients defined as cardioprotective by physicians.
    S Afr Med J; 1997 Feb; 87 Suppl 1():C60. PubMed ID: 9186455
    [No Abstract]   [Full Text] [Related]  

  • 20. From Tritace to Tri-Plen - the South African journey.
    Cardiovasc J Afr; 2009; 20(1):69-70. PubMed ID: 19287820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.